错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effects of postoperative oral elemental nutritional supplement on skeletal muscle loss after gastrectomy for gastric cancer

  • Kazuhiro Nishikawa,
  • Yutaka Kimura,
  • Kentaro Kishi,
  • Kentaro Inoue,
  • Jin Matsuyama,
  • Yusuke Akamaru,
  • Shigeyuki Tamura,
  • Junji Kawada,
  • Tomono Kawase,
  • Ryohei Kawabata,
  • Yoshiyuki Fujiwara,
  • Hitoshi Kanno,
  • Takeshi Yamada,
  • Toshio Shimokawa,
  • Hiroshi Imamura

摘要

Background

We previously showed that daily nutritional intervention with an oral elemental diet (ED) at 300 kcal/day for 6–8 weeks postoperatively decreased the percentage of body weight loss (%BWL), and that the effect was maintained for 1 year. This post hoc analysis aimed to determine whether this intervention decreased skeletal muscle mass loss 1-year post-gastrectomy.

Methods

Data from consecutive, untreated patients with histopathologically confirmed stage I–III gastric adenocarcinoma who planned to undergo total gastrectomy (TG) or distal gastrectomy (DG) and were enrolled in a previously published randomized trial were used. The primary endpoint was the percentage of skeletal muscle mass index (%SMI) loss from baseline at 1 year postoperatively, based on abdominal computed tomography images obtained preoperatively and at 1 year postoperatively.

Results

The overall median %SMI loss was lower in the ED versus control group, but the difference was not significant. The difference in %SMI loss in the ED and control groups was greater in patients with TG (10.1 vs. 13.0; P = 0.12) than in those with DG (5.5 vs. 6.8; P = 0.69). A correlation was observed between %BWL and %SMI loss in both groups (ED group, coefficient 0.591; control group, coefficient 0.644; P < 0.001 for both). Type of gastrectomy (coefficient 7.38; P = 0.001) and disease stage (coefficient − 6.43; P = 0.04) were independent predictors of postoperative skeletal muscle mass loss.

Conclusion

ED administration for 6–8 weeks following gastrectomy had no inhibitory effect on skeletal muscle loss at 1 year postoperatively.

Clinical Trial Registration

UMIN000023455.